Urinary Catheters Market to Reach US$ 6.59 Billion by 2033 at 6.04% CAGR; North America Leads with 40% Share - Key Players: B. Braun, Coloplast, C.R. Bard

The global Urinary Catheters Market reached US$ 3.90 billion in 2024 and is expected to reach US$ 6.59 billion by 2033, growing at a CAGR of 6.04% during the forecast period 2025-2033. Market growth is driven by the rising prevalence of urinary incontinence, benign prostatic hyperplasia (BPH), spinal cord injuries, and chronic kidney diseases, along with the increasing geriatric population worldwide.

Urinary catheters are essential medical devices used in hospitals, long-term care facilities, and home healthcare settings to manage urinary retention and incontinence. Technological advancements such as antimicrobial-coated catheters, hydrophilic coatings, and improved materials to reduce catheter-associated urinary tract infections (CAUTIs) are supporting adoption. Additionally, growing demand for minimally invasive care, expansion of home healthcare services, and improved awareness of urological health are contributing to the steady expansion of the urinary catheters market globally.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/urinary-catheters-market?sai-v

The Urinary Catheters Market refers to the global market for medical devices designed to drain urine from the bladder for patients requiring short-term or long-term urinary management in clinical and homecare settings.

Key Developments
✅ December 2025: Healthcare facilities continued expanding use of advanced urinary catheters featuring antimicrobial coatings and hydrophilic surfaces to lower infection rates and improve patient comfort.

✅ October 2025: Manufacturers launched next-generation intermittent and indwelling catheter systems with integrated sensors and feedback mechanisms to support real-time monitoring and reduce complications.

✅ September 2025: Hospitals and long-term care centers increased adoption of single-use sterile catheter kits to minimize cross-contamination and support infection control protocols.

✅ July 2025: Regulatory authorities updated quality standards and performance guidelines for urinary catheter devices to enhance safety, durability, and biocompatibility across clinical settings.

✅ May 2025: Product innovation accelerated with introduction of ergonomic designs and patient-centric features aimed at improving ease of use and reducing patient discomfort in home and clinical environments.

✅ March 2025: Awareness initiatives by urology associations highlighted best practices for catheter management and emphasized reduction of catheter-associated urinary tract infections (CAUTI) through evidence-based care pathways.

Mergers & Acquisitions
✅ November 2025: A leading medical device company acquired a urinary catheter specialist to broaden its urology portfolio and expand offerings in advanced catheter technologies.

✅ August 2025: A global healthcare technology provider partnered with a biomaterials firm to co-develop next-generation antimicrobial catheter coatings and surface treatments.

✅ June 2025: A regional medical technology investor group acquired a catheter manufacturing business to support production scale-up and enhance distribution across key markets.

Key Players
B. Braun Melsungen | Coloplast A/S | C.R. Bard, Inc. | Hollister Incorporated | Medtronic plc | Teleflex Incorporation | ConvaTec Group plc | Urocare Products, Inc.

Key Highlights
B. Braun Melsungen - Holds 19.5% share, driven by its broad portfolio of urology and continence care products, strong hospital presence, and consistent product innovation.

Coloplast A/S - Holds 18.2% share, supported by leadership in ostomy and continence care, strong brand recognition, and high adoption in homecare and clinical settings.

C.R. Bard, Inc. - Holds 15.6% share, benefiting from advanced catheter technologies, long-standing clinician trust, and integration within BD's global medical device network.

Hollister Incorporated - Holds 13.4% share, driven by specialized urological and continence solutions, patient-centric designs, and strong penetration in long-term care facilities.

Medtronic plc - Holds 12.1% share, supported by advanced minimally invasive urology devices, strong R&D capabilities, and global healthcare system partnerships.

Teleflex Incorporation - Holds 9.8% share, leveraging expertise in catheterization and access technologies with growing demand in acute and critical care settings.

ConvaTec Group plc - Holds 8.3% share, driven by its diversified medical products portfolio, focus on chronic care management, and expanding global footprint.

Urocare Products, Inc. - Holds 3.1% share, supported by niche urological care products and steady demand in specialized and outpatient care segments.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=urinary-catheters-market?sai-v
(Purchase 2 or more Reports and get 50% Discount)

Market Drivers
- Increasing prevalence of urinary incontinence, neurogenic bladder disorders, and age-related urological conditions driving demand for urinary catheterization solutions.

- Growing geriatric population globally, who are more prone to chronic illnesses and require long-term catheter care and management.

- Rising hospital admissions, surgical procedures, and ICU stays necessitating catheter use for accurate urinary drainage and patient monitoring.

- Advancements in catheter design including antimicrobial coatings, biocompatible materials, and silicone-based products reducing infection risks and improving patient comfort.

- Expansion of home healthcare services and growing preference for outpatient care increasing use of intermittent self-catheters and portable systems.

- Increasing awareness among patients and caregivers about proper catheter care, reducing complications, and improving quality of life.

- Strong focus on reducing catheter-associated urinary tract infections (CAUTIs) through adoption of advanced catheter technologies and infection control protocols.

- Supportive reimbursement frameworks and rising healthcare expenditure enabling broader access to high-quality catheter products.

Industry Developments
- Launch of next-generation catheter products with antimicrobial/antibiofilm coatings to reduce infection incidence and improve patient outcomes.

- Development of hydrophilic, low-friction, and ergonomic catheter designs enhancing ease of use, comfort, and patient adherence.

- Introduction of pre-lubricated and single-use intermittent catheters to minimize contamination risk, promote hygiene, and simplify self-catheterization.

- Collaborations between medical device manufacturers and healthcare providers to develop patient education programs and bundled care solutions.

- Investments in R&D for biodegradable and eco-friendly catheter materials addressing environmental concerns associated with single-use products.

- Strategic partnerships, acquisitions, and licensing agreements to expand product portfolios and geographic presence in key markets.

- Integration of smart features like sensors for urine flow monitoring and wireless connectivity to support remote patient care.

- Expansion of distribution networks and e-commerce platforms to improve product access in home care and emerging markets.

Regional Insights
North America - 40% share: "Driven by advanced healthcare infrastructure, high prevalence of urological conditions, strong reimbursement coverage, increased adoption of innovative catheter technologies, and significant use in acute and long-term care settings."

Europe - 28% share: "Supported by established healthcare systems, stringent infection control protocols, growing emphasis on reducing CAUTIs, and increasing utilization of hydrophilic and intermittent catheters."

Asia Pacific - 24% share: "Fueled by expanding healthcare access, rising geriatric population, increasing surgical procedures, growing awareness of catheter care, and improving reimbursement policies."

Latin America - 6% share: "Boosted by improving healthcare infrastructure, rising incidence of urinary disorders, expanding home healthcare services, and gradual adoption of advanced catheter solutions."

Middle East & Africa - 2% share: "Driven by growing investments in healthcare improvement, increasing awareness about urological care, and expanding access to modern catheter products."

speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/urinary-catheters-market?sai-v
Key Segments

By Product Type
Indwelling (Foley) catheters hold the largest share of the market, driven by their widespread use in hospitals for short- and long-term urinary drainage, post-surgical care, and critical care settings. Internal urinary catheters represent a significant segment, supported by increasing adoption in patients requiring continuous bladder management. External urinary catheters are witnessing steady growth, driven by rising preference for non-invasive options, improved patient comfort, and reduced risk of catheter-associated urinary tract infections.

By Application
Urinary incontinence represents the dominant application segment, driven by the growing geriatric population and increasing prevalence of chronic conditions affecting bladder control. Benign prostate hyperplasia (BPH) holds a notable share, supported by the high incidence of prostate-related urinary complications among aging male populations. Spinal cord injury applications are growing steadily, driven by the need for long-term urinary management solutions in patients with neurological impairments. Other applications, including post-operative care and urinary retention due to various medical conditions, contribute to overall market growth.

By End User
Hospitals account for the largest end-user segment, driven by high patient volumes, availability of skilled healthcare professionals, and extensive use of urinary catheters in inpatient and surgical care. Ambulatory surgery clinics represent a growing segment, supported by the increasing number of outpatient procedures requiring temporary catheterization. Other end users, including long-term care facilities and home healthcare settings, contribute steadily to market expansion due to rising demand for chronic care and home-based patient management solutions.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.